Added to YB: 2025-11-26
Pitch date: 2025-11-24
ETON [bullish]
Eton Pharmaceuticals, Inc.
+13.31%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
Market Cap
$451.3M
Pitch Price
$16.08
Price Target
29.67 (+63%)
Dividend
N/A
EV/EBITDA
93.16
P/E
-65.04
EV/Sales
6.33
Sector
Pharmaceuticals
Category
growth
Show full summary:
Investment pitch: Eton Pharmaceuticals $ETON
ETON: Rare disease specialty pharma at operational inflection w/ 129% YoY Q3 rev growth (19th consecutive quarter), $12M op cash flow, 75% adj gross margin. KHINDIVI approved May '25, ET-600 NDA targeted Feb '26. $80M annual run rate vs $441M EV. Analyst avg price target $29.67 (+80% upside) vs $16.46 current.
Read full article (11 min)